injecting indocyanine green (ICG) dye Intraoperative
injecting indocyanine green (ICG) dye Intraoperative: injecting indocyanine green (ICG) dye Intraoperative for patients with endometrial cancer
Study summary
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) injection in endometrial cancer.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* • 1.Age \>18 and \<80 years old
* 2\. The pathological diagnosis was epithelial ovarian cancer
* 3.Survival time is expected to exceed 3 months
* 4.Signed consent form
Exclusion Criteria:
* 1\. Patients with myocardial infarction or stroke, or unstable angina pectoris or decompensated heart function
* 2.Patients with a history of exhaustion or deep vein thrombosis;
* 3\. Liver insufficiency (transaminase \>2.5 times the upper limit of the standard);
* 4\. Renal insufficiency (serum muscle liver \>2 times the standard upper limit);
* 5\. Pregnancy and perinatal patients;
* 6\. History of major organ transplantation and immune disease;
* 7\. Psychiatric condition or language barriers
* 8\. Alcohol or drug abuser (current or previous)
* 9\. Unable or unwilling to sign informed consent or comply with study requirements;
* 10\. Patients with other malignant tumors.
Primary outcome measure(s)
paraaortic Sentinel lymph node detection rates — intraoperative day0 IGC positive Sentinel lymph node detection in paraaoritc lymph node will be assessed
Sentinel lymph node technique accuracy — postoperative up to day7 Sensitivity and specificity measure of the sentinel lymph node for detecting the lymphatic metastasis
Trial sites (1)
Facility
City
Region
Status
Qilu Hospital，Shandong University
Jinan
Shandong
Recruiting
More Qilu Hospital of Shandong University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.